The Process Development Blog

See how CrysAI™ applies deep learning to crystallization and cell imaging—automating segmentation, improving reproducibility, and scaling insight.

APC & VLE Therapeutics is looking forward to seeing you at this CLS event in San Diego which brings together upstream, downstream, bioproduction, analytical, and formulation professionals to advance the manufacture, quality, and control of biological and genetic therapies.

Building on this foundation, APC announces a strategic partnership with METTLER TOLEDO AutoChem, a global leader in automated reactor technology, process analytical tools (PAT), and chemical development software platforms. Together, the partnership seeks to build a fully integrated digital development environment—advancing how data, decisions, and design converge across the full CMC lifecycle.

This paper explores the development of a chromatography-based platform process for adeno-associated virus (AAV) purification, focusing on exploiting AAV characteristics and addressing impurities to enable scalable and standardized gene therapy manufacturing.

APC & VLE Therapeutics is looking forward to seeing you at Biomanufacturing World Summit, in San Diego which brings together upstream, downstream, bioproduction, analytical, and formulation professionals to advance the manufacture, quality, and control of biological and genetic therapies.

APC & VLE Therapeutics is looking forward to seeing you at AIChE, in Boston which brings together upstream, downstream, bioproduction, analytical, and formulation professionals to advance the manufacture, quality, and control of biological and genetic therapies.

APC & VLE Therapeutics is looking forward to seeing you at World Vaccine Congress, in Amsterdam which brings together upstream, downstream, bioproduction, analytical, and formulation professionals to advance the manufacture, quality, and control of biological and genetic therapies.

The Medicine Accelerator is expanding its digital business with strategic new roles to scale iAchieve®—a first-of-its-kind digital CMC platform built on 100,000s of expert-led experiments and thousands of contextualized programs—to accelerate medicine development and manufacturing globally.

The Medicine Accelerator (APC and VLE Therapeutics) has been recognized as one of Ireland’s Top 100 Companies for Workplace Wellbeing by Business & Finance and Ibec—highlighting its commitment to fostering a healthy, high-performing workplace through the BeWell@Cherrywood initiative and KeepWell™ accreditation.